Dr. James A. Goldman, MD
Endocrinology & Diabetes (Endocrinology, Diabetes & Metabolism Physician)
- Medicare participating
At a glance
- Medical school
- University of Massachusetts Medical School (1979)
- Years since graduation
- 47
- In the NPI registry since
- 2005
- Medicare patients seen, 2024
- 1,961
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 1979Medical school: University of Massachusetts Medical School
- 2005Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Endocrinology, Diabetes & Metabolism Physician primary
MA license 49314
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Medical groups
- Atrius Health Inc (1,222 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 1,961
- Services billed
- 3,958
- Patients’ average age
- 74
| Service | Times | Patients |
|---|---|---|
| Dxa bone density measurement of hip, pelvis, spine | 848 | 840 |
| Dxa bone density measurement of hip, pelvis, spine including spine fracture assessment | 770 | 768 |
| Dxa bone density measurement of forearm, finger, hand, or foot | 677 | 677 |
| Calculation of trabecular bone score (tbs) using imaging data with interpretation and report on fracture risk | 65 | 65 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Payments from drug and device companies
In 2025, 1 companies reported 10 payments worth $1,890 in total to this clinician.
| Vertex Pharmaceuticals Incorporated | $1,890 |
|---|
| Consulting Fee | $1,890 |
|---|
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| Vertex Pharmaceuticals Incorporated Jan 15, 2025 | Consulting Fee | $473 |
| Vertex Pharmaceuticals Incorporated Jul 16, 2025 | Consulting Fee | $158 |
| Vertex Pharmaceuticals Incorporated Aug 27, 2025 | Consulting Fee | $158 |
| Vertex Pharmaceuticals Incorporated Jan 29, 2025 | Consulting Fee | $158 |
| Vertex Pharmaceuticals Incorporated Apr 29, 2025 | Consulting Fee | $158 |
| Vertex Pharmaceuticals Incorporated Jan 22, 2025 | Consulting Fee | $158 |
| Vertex Pharmaceuticals Incorporated Jun 25, 2025 | Consulting Fee | $158 |
| Vertex Pharmaceuticals Incorporated Oct 15, 2025 | Consulting Fee | $158 |
| Vertex Pharmaceuticals Incorporated May 14, 2025 | Consulting Fee | $158 |
| Vertex Pharmaceuticals Incorporated Mar 26, 2025 | Consulting Fee | $158 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.